Globeflex Capital’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.48K | Hold |
33
| – | – | ﹤0.01% | 385 |
|
|
2026
Q1 | $1.86K | Hold |
33
| – | – | ﹤0.01% | 385 |
|
|
2025
Q4 | $2.65K | Hold |
33
| – | – | ﹤0.01% | 393 |
|
|
2025
Q3 | $1.61K | Hold |
33
| – | – | ﹤0.01% | 399 |
|
|
2025
Q2 | $2.46K | Hold |
33
| – | – | ﹤0.01% | 411 |
|
|
2025
Q1 | $2.1K | Sell |
33
-1,148
| -97% | -$78.1K | ﹤0.01% | 417 |
|
|
2024
Q4 | $92.2K | Hold |
1,181
| – | – | 0.01% | 392 |
|
|
2024
Q3 | $94.9K | Hold |
1,181
| – | – | 0.01% | 391 |
|
|
2024
Q2 | $97.7K | Hold |
1,181
| – | – | 0.01% | 382 |
|
|
2024
Q1 | $101K | Hold |
1,181
| – | – | 0.01% | 397 |
|
|
2023
Q4 | $101K | Hold |
1,181
| – | – | 0.01% | 397 |
|
|
2023
Q3 | $106K | Hold |
1,181
| – | – | 0.01% | 373 |
|
|
2023
Q2 | $101K | Hold |
1,181
| – | – | 0.01% | 385 |
|
|
2023
Q1 | $97.7K | Buy |
1,181
+22
| +2% | +$1.78K | 0.01% | 396 |
|
|
2022
Q4 | $91.2K | Hold |
1,159
| – | – | 0.01% | 406 |
|
|
2022
Q3 | $86K | Buy |
+1,159
| New | +$83.2K | 0.01% | 417 |
|
|
2020
Q3 | – | Sell |
-9,455
| Closed | -$847K | – | 492 |
|
|
2020
Q2 | $847K | Sell |
9,455
-2,130
| -18% | -$215K | 0.21% | 162 |
|
|
2020
Q1 | $1.16M | Hold |
11,585
| – | – | 0.36% | 78 |
|
|
2019
Q4 | $1.33M | Buy |
11,585
+1,515
| +15% | +$183K | 0.25% | 125 |
|
|
2019
Q3 | $1.27M | Buy |
10,070
+7,729
| +330% | +$981K | 0.28% | 103 |
|
|
2019
Q2 | $282K | Hold |
2,341
| – | – | 0.06% | 362 |
|
|
2019
Q1 | $205K | Hold |
2,341
| – | – | 0.04% | 372 |
|
|
2018
Q4 | $234K | Hold |
2,341
| – | – | 0.06% | 355 |
|
|
2018
Q3 | $268K | Buy |
+2,341
| New | +$242K | 0.05% | 374 |
|
|
2017
Q2 | – | Sell |
-25
| Closed | -$1K | – | 434 |
|
|
2017
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 451 |
|
|
2016
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 412 |
|
|
2016
Q3 | $1K | Buy |
+25
| New | +$858 | ﹤0.01% | 400 |
|
|
2014
Q1 | – | Sell |
-18,713
| Closed | -$788K | – | 648 |
|
|
2013
Q4 | $788K | Sell |
18,713
-4,440
| -19% | -$183K | 0.1% | 246 |
|
|
2013
Q3 | $923K | Hold |
23,153
| – | – | 0.12% | 222 |
|
|
2013
Q2 | $957K | Buy |
+23,153
| New | +$937K | 0.13% | 202 |
|
Other funds holding HAE
AI
Globeflex Capital's HAE Position: Q2 2026 in Review
Globeflex Capital held its Haemonetics (HAE) position steady in Q2 2026 at 33 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #385.
Globeflex Capital first reported a position in HAE in Q2 2013 and has held it in 30 quarters since. The position peaked at $1.33M in Q4 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Globeflex Capital held 33 shares of Haemonetics worth $2.48K as of Q2 2026.
- Globeflex Capital left its Haemonetics share count unchanged in Q2 2026.
- Haemonetics made up ﹤0.01% of Globeflex Capital's portfolio in Q2 2026, its #385 holding.
- Globeflex Capital first reported a position in Haemonetics in Q2 2013 and has held it in 30 quarters since.
- Globeflex Capital's Haemonetics position peaked at $1.33M in Q4 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.